Dexcom Inc (DXCM)

$71.63 -0.90 (-1.24%)
Market Cap 28.49B
Revenue (ttm) 4.03B
Net Income (ttm) 576.20M
EPS (ttm) N/A
PE Ratio 39.78
Forward PE 29.97
Profit Margin 14.29%
Debt to Equity Ratio 0.45
Volume 5,025,900
Avg Vol 5,227,552
Day's Range N/A - N/A
Shares Out 390.02M
Stochastic %K 34%
Beta 1.48
Analysts Strong Sell
Price Target $85.20

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized thir...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
CmonManGiveMeABreak
CmonManGiveMeABreak Feb. 3 at 8:11 PM
$DXCM wtf
0 · Reply
purdiestpam
purdiestpam Feb. 3 at 5:41 PM
$DXCM sold 130 shares. Sitting at 400 with long calls too. Not worth having so much riding on earnings even thought I’m sure they’ll hit
1 · Reply
Mobagri
Mobagri Feb. 3 at 3:04 PM
$DXCM Any positive news on Feb 12 th and this stock will shoot up to $90 the day after
0 · Reply
Mobagri
Mobagri Feb. 3 at 3:03 PM
$DXCM sENS troll
0 · Reply
jameslee09
jameslee09 Feb. 3 at 2:35 PM
$DXCM is it true dxcm negotiating Sensonic....
1 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Feb. 3 at 1:58 AM
$DXCM
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Feb. 3 at 1:55 AM
$DXCM only about 4 millions active cgm users in US comparing to 150 millions iphone users in US! buy now and thanks me later
0 · Reply
ckjamesst
ckjamesst Jan. 30 at 4:49 PM
$DXCM buy boys buy Monday 75+
0 · Reply
ckjamesst
ckjamesst Jan. 30 at 4:26 PM
$DXCM told you it will go up Monday buy buy buy
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Jan. 30 at 2:44 PM
$DXCM let it run one time
1 · Reply
Latest News on DXCM
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 29, 2026, 5:00 PM EST - 5 days ago

HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

Jan 27, 2026, 8:30 AM EST - 7 days ago

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 12:06 PM EST - 19 days ago

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 13, 2026, 5:24 PM EST - 21 days ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 3:35 PM EST - 21 days ago

DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Jan 12, 2026, 7:30 AM EST - 22 days ago

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Jan 7, 2026, 9:00 AM EST - 27 days ago

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCM

Dec 22, 2025, 3:50 PM EST - 6 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCM

4 Reasons Why DexCom Could Be A Good Buy For 2026

Dec 16, 2025, 7:37 AM EST - 7 weeks ago

4 Reasons Why DexCom Could Be A Good Buy For 2026

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Dec 11, 2025, 9:00 AM EST - 7 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

Dec 11, 2025, 3:45 AM EST - 7 weeks ago

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

ABT AI ASND AXON AZO CPRT HOOD

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights Before Upcoming Deadlines

Dec 4, 2025, 6:11 PM EST - 2 months ago

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights Before Upcoming Deadlines

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

Dec 4, 2025, 8:02 AM EST - 2 months ago

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

Virtus Silvant Mid-Cap Growth Fund Q3 2025 Performance Review

Nov 26, 2025, 1:38 PM EST - 2 months ago

Virtus Silvant Mid-Cap Growth Fund Q3 2025 Performance Review

AFRM AJG ALAB ALNY AXON FICO HOOD

Touchstone Sands Capital Select Growth Fund Q3 Contributors And Detractors

Nov 26, 2025, 1:40 AM EST - 2 months ago

Touchstone Sands Capital Select Growth Fund Q3 Contributors And Detractors

APP AVGO AXON DDOG GOOG GOOGL ICE

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights

Nov 25, 2025, 7:15 PM EST - 2 months ago

Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth Investors to Contact the Firm Regarding Their Rights

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

Nov 25, 2025, 9:00 AM EST - 2 months ago

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.

Nov 24, 2025, 10:00 AM EST - 2 months ago

Ademi & Fruchter LLP Investigates Claims of Securities Fraud against DexCom, Inc.

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

Nov 20, 2025, 8:30 AM EST - 2 months ago

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

Dexcom partners with Disabled American Veterans as part of new strategic initiative

Nov 19, 2025, 11:05 AM EST - 2 months ago

Dexcom partners with Disabled American Veterans as part of new strategic initiative

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

Nov 19, 2025, 8:30 AM EST - 2 months ago

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

Nov 17, 2025, 11:24 AM EST - 2 months ago

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

ADBE ALGN BLDR CARR CMG CPRT CRM

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT Investors With Large Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Nov 14, 2025, 10:51 AM EST - 2 months ago

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT Investors With Large Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

Nov 14, 2025, 8:00 AM EST - 2 months ago

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

Nov 11, 2025, 9:18 AM EST - 3 months ago

Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

DXCM STOCK NOTICE: DexCom, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 26 Deadline

Nov 10, 2025, 6:07 AM EST - 3 months ago

DXCM STOCK NOTICE: DexCom, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 26 Deadline

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

Nov 6, 2025, 8:34 PM EST - 3 months ago

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

Is Dexcom Stock A Buy Now?

Nov 3, 2025, 11:05 AM EST - 3 months ago

Is Dexcom Stock A Buy Now?

S&P 500 Gains and Losses Today: Amazon Stock Surges as Cloud Business Boosts Earnings; DexCom Drops

Oct 31, 2025, 4:55 PM EDT - 3 months ago

S&P 500 Gains and Losses Today: Amazon Stock Surges as Cloud Business Boosts Earnings; DexCom Drops

AMZN

DexCom Stock Is the Worst Performer in the S&P 500. Here's Why.

Oct 31, 2025, 10:17 AM EDT - 3 months ago

DexCom Stock Is the Worst Performer in the S&P 500. Here's Why.

20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Oct 31, 2025, 10:05 AM EDT - 3 months ago

20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Dexcom shares extend fall over 2026 growth concerns

Oct 31, 2025, 6:51 AM EDT - 3 months ago

Dexcom shares extend fall over 2026 growth concerns

DexCom, Inc. (DXCM) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 8:26 PM EDT - 3 months ago

DexCom, Inc. (DXCM) Q3 2025 Earnings Call Transcript

Dexcom beats quarterly estimates on strong demand for glucose monitors

Oct 30, 2025, 4:03 PM EDT - 3 months ago

Dexcom beats quarterly estimates on strong demand for glucose monitors

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

Oct 30, 2025, 4:02 PM EDT - 3 months ago

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

Oct 28, 2025, 2:04 PM EDT - 3 months ago

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

Dexcom Appoints Euan Ashley to Board of Directors

Oct 27, 2025, 4:15 PM EDT - 3 months ago

Dexcom Appoints Euan Ashley to Board of Directors

10 stocks primed for growth in the S&P 500's cheapest sectors

Oct 23, 2025, 11:29 AM EDT - 3 months ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO FITB HOOD KKR

CmonManGiveMeABreak
CmonManGiveMeABreak Feb. 3 at 8:11 PM
$DXCM wtf
0 · Reply
purdiestpam
purdiestpam Feb. 3 at 5:41 PM
$DXCM sold 130 shares. Sitting at 400 with long calls too. Not worth having so much riding on earnings even thought I’m sure they’ll hit
1 · Reply
Mobagri
Mobagri Feb. 3 at 3:04 PM
$DXCM Any positive news on Feb 12 th and this stock will shoot up to $90 the day after
0 · Reply
Mobagri
Mobagri Feb. 3 at 3:03 PM
$DXCM sENS troll
0 · Reply
jameslee09
jameslee09 Feb. 3 at 2:35 PM
$DXCM is it true dxcm negotiating Sensonic....
1 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Feb. 3 at 1:58 AM
$DXCM
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Feb. 3 at 1:55 AM
$DXCM only about 4 millions active cgm users in US comparing to 150 millions iphone users in US! buy now and thanks me later
0 · Reply
ckjamesst
ckjamesst Jan. 30 at 4:49 PM
$DXCM buy boys buy Monday 75+
0 · Reply
ckjamesst
ckjamesst Jan. 30 at 4:26 PM
$DXCM told you it will go up Monday buy buy buy
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Jan. 30 at 2:44 PM
$DXCM let it run one time
1 · Reply
Mobagri
Mobagri Jan. 30 at 2:37 PM
$DXCM yup
1 · Reply
Mobagri
Mobagri Jan. 30 at 2:37 PM
$DXCM
0 · Reply
Mobagri
Mobagri Jan. 30 at 2:36 PM
$DXCM
0 · Reply
Let_us_Rocket
Let_us_Rocket Jan. 30 at 1:19 PM
$SENS $DXCM $ABT $JNJ If you want your money back in the diabetes sector, come to $NVO Super bullish market launch, far above all estimated sales expectations — the new pill is already exploding, and the stock looks next in line 🚀🔥
0 · Reply
rubraquercus
rubraquercus Jan. 30 at 5:29 AM
$DXCM Yikes...unauthorized, major changes to sensors (specifically the coating) were made without proper FDA approval, causing increased inaccuracy.
0 · Reply
rubraquercus
rubraquercus Jan. 30 at 4:50 AM
$DXCM The manufacturing delays right now told to me by/at CVS caremark are very real, so is the 5 year chart...
0 · Reply
Mobagri
Mobagri Jan. 30 at 3:22 AM
$DXCM headed to $80 before earnings
0 · Reply
ckjamesst
ckjamesst Jan. 29 at 10:22 PM
$DXCM tomorrow we going down…. Huge play tomorrow and next week keep trying we got this boys!
0 · Reply
ckjamesst
ckjamesst Jan. 29 at 2:52 PM
$DXCM hoping 70 or lower before earnings
0 · Reply
ckjamesst
ckjamesst Jan. 29 at 1:43 PM
$DXCM I might be wrong but there might be gap around 65-66 level just waiting patiently
0 · Reply
ckjamesst
ckjamesst Jan. 29 at 12:23 PM
$DXCM we need a healthy pull back here not buying this high
0 · Reply
Mobagri
Mobagri Jan. 29 at 6:03 AM
$DXCM
0 · Reply